---
title: Gentian Diagnostics presents at the DNB Nordic Healthcare Conference
description: healthcare conference
---

Moss, 25 November 2025

The CEO of Gentian Diagnostics, Mr. Matti Heinonen, will today give a company presentation at the DNB Nordic Healthcare conference.

Please find the presentation attached.

For further information, please contact:

Njaal Kind CFO, Gentian Diagnostics AS  
E-mail: njaal.kind@gentian.no  
+47 919 06 525

[Presentation DNB healthcare 2025](https://www.gentian.com/hubfs/Gentian%20Diagnostics%20Nov%2025%202025%20company%20presentation%20DNB.pdf)

### You may also read

[Jul 02, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-presents-at-the-dnb-nordic-healthcare-conference-3#)

##### [Gentian Diagnostics: Invitation to presentation of second quarter results](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

Gentian Diagnostics ASA will present its second quarter 2026 results on 9 July 2026 at 09.00 CEST. The..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

[Jun 24, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-presents-at-the-dnb-nordic-healthcare-conference-3#)

##### [ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

Amsterdam / Moss, 24 June 2026 ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

[May 29, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-presents-at-the-dnb-nordic-healthcare-conference-3#)

##### [Mandatory notification of trade](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)

Moss, 29 May 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)